
Are you or a loved one facing the challenges of Parkinson’s disease, searching for options that go beyond traditional medications? Stem cell therapy is now entering clinical reality, thanks to breakthroughs from world-leading universities and medical centers. Here’s how the science stands today and what this means for patients considering the regenerative path.
What Is Stem Cell Therapy for Parkinson’s Disease?
Stem cell therapy aims to replace the dopamine-producing neurons in the brain destroyed by Parkinson’s disease. Most university-based clinical trials now use High Quality Cellular Therapies that are carefully reprogrammed to become the specific dopamine neurons lost in Parkinson’s (Sawamoto et al., 2025; UCI Health, 2025; Harvard Stem Cell Institute, 2025).
How Does It Work, Scientifically?
Is Stem Cell Therapy Safe?
What Kind of Results Can Patients Expect?
Why Choose Stem Cell Mexico?
Our practice partners with global research teams, uses the highest safety and cell-processing standards, and tailo*
References
Sawamoto, N., et al. (2025). Phase I/II trial of iPS-cell-derived dopaminergic cells for Parkinson’s disease. Nature, 617, 279–287. https://www.nature.com/articles/s41586-025-08700-0
Tabar, V., et al. (2025). Phase I trial of hES cell-derived dopaminergic neurons for Parkinson’s disease. Nature, 617, 288–297. https://www.nature.com/articles/s41586-025-08845-y
UCI Health. (2025). Stem-cell therapy is a ‘big leap’ for Parkinson’s treatment. https://www.ucihealth.org/about-us/news/2025/04/parkinsons-study-nature
Mokhtari, Y.G., et al. (2025). Stem cell therapy for Parkinson’s disease: A new hope based on new biological insights. Frontiers in Neuroscience, 19(4), 1517–1529. https://pubmed.ncbi.nlm.nih.gov/40476258/
Harvard Stem Cell Institute. (2025). Parkinson’s Disease. https://www.hsci.harvard.edu/parkinsons-disease-0
Lund University. (2024). Update on STEM-PD clinical trial—stem cell-based transplant for Parkinson’s disease. https://www.lunduniversity.lu.se/article/update-stem-pd-clinical-trial-stem-cell-based-transplant-parkinsons-disease

